Xun Gui

2.9k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Xun Gui is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Xun Gui has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Xun Gui's work include Immune Cell Function and Interaction (8 papers), Influenza Virus Research Studies (5 papers) and Respiratory viral infections research (4 papers). Xun Gui is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Influenza Virus Research Studies (5 papers) and Respiratory viral infections research (4 papers). Xun Gui collaborates with scholars based in United States, China and Hong Kong. Xun Gui's co-authors include Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama, Yasuaki Anami, Timothy Y. Huang, Yingjun Zhao, Lu-Lin Jiang, Bing Zhu, Xilin Wu and Huaxi Xu and has published in prestigious journals such as Nature Communications, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Xun Gui

28 papers receiving 1.4k citations

Hit Papers

TREM2 Is a Receptor for β-Amyloid that Mediates Microglia... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xun Gui United States 15 398 375 335 297 293 29 1.5k
Abdoulaye Sène United States 18 133 0.3× 234 0.6× 523 1.6× 167 0.6× 132 0.5× 47 1.5k
Long Cao China 18 356 0.9× 409 1.1× 689 2.1× 100 0.3× 198 0.7× 44 2.0k
James A. Eddy United States 17 221 0.6× 218 0.6× 948 2.8× 35 0.1× 121 0.4× 24 1.8k
Wencke Walter Germany 16 69 0.2× 394 1.1× 1.0k 3.1× 43 0.1× 196 0.7× 85 2.1k
Anahit Ghochikyan United States 27 556 1.4× 350 0.9× 669 2.0× 76 0.3× 93 0.3× 62 1.8k
Carlo Russo United States 19 113 0.3× 695 1.9× 334 1.0× 34 0.1× 191 0.7× 78 1.7k
Nadav Cohen Israel 4 87 0.2× 357 1.0× 1.2k 3.7× 120 0.4× 110 0.4× 5 1.6k
Roel C. van der Veen United States 19 167 0.4× 690 1.8× 254 0.8× 95 0.3× 149 0.5× 29 1.2k
Henry Loeffler‐Wirth Germany 21 36 0.1× 263 0.7× 1.2k 3.6× 43 0.1× 211 0.7× 80 2.0k
Ina Rothenaigner Germany 16 140 0.4× 114 0.3× 463 1.4× 103 0.3× 101 0.3× 27 1.0k

Countries citing papers authored by Xun Gui

Since Specialization
Citations

This map shows the geographic impact of Xun Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Gui more than expected).

Fields of papers citing papers by Xun Gui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xun Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Gui. The network helps show where Xun Gui may publish in the future.

Co-authorship network of co-authors of Xun Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Xun Gui. A scholar is included among the top collaborators of Xun Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xun Gui. Xun Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Cuicui, Hongyu Sun, Yulei Du, et al.. (2025). Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization. Journal of Experimental & Clinical Cancer Research. 44(1). 1–1. 4 indexed citations
2.
Wang, Rui, Peng Fang, Xi Chen, et al.. (2025). Overcoming multidrug resistance in gastrointestinal cancers with a CDH17-targeted ADC conjugated to a DNA topoisomerase inhibitor. Cell Reports Medicine. 6(7). 102213–102213. 2 indexed citations
3.
Zhang, Chang, Shasha Jiao, Wen G. Jiang, et al.. (2025). IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade. npj Precision Oncology. 9(1). 138–138. 2 indexed citations
5.
Morse, Joshua, Xun Gui, Mi Deng, et al.. (2023). Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. PubMed. 7(1). 13–27. 3 indexed citations
6.
Wang, Rongjuan, Chang Zhang, Junchao Wang, et al.. (2022). Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment. Theranostics. 13(1). 148–160. 30 indexed citations
7.
Wu, Guojin, Yixiang Xu, Robbie D. Schultz, et al.. (2021). LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis. Nature Cancer. 2(11). 1170–1184. 38 indexed citations
8.
Li, Leike, Constance L. Atkins, Meng Wang, et al.. (2021). Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment. eLife. 10. 27 indexed citations
9.
Chen, Jianxin, Xun Gui, Luan Chen, & Tao He. (2020). Distributed Energy Trading Model based on Graphene Blockchain. 934–939. 1 indexed citations
10.
Ye, Xiaohua, Xun Gui, Daniel C. Freed, et al.. (2019). Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection. PLoS Pathogens. 15(7). e1007914–e1007914. 14 indexed citations
11.
Zhao, Yingjun, Xilin Wu, Xiaoguang Li, et al.. (2018). TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function. Neuron. 97(5). 1023–1031.e7. 519 indexed citations breakdown →
12.
Anami, Yasuaki, Chisato M. Yamazaki, Wei Xiong, et al.. (2018). Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice. Nature Communications. 9(1). 2512–2512. 161 indexed citations
13.
Anami, Yasuaki, Wei Xiong, Xun Gui, et al.. (2017). Enzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency. Organic & Biomolecular Chemistry. 15(26). 5635–5642. 69 indexed citations
14.
Meng, Weixu, Aimin Tang, Xiaohua Ye, et al.. (2017). Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody. Antimicrobial Agents and Chemotherapy. 62(1). 16 indexed citations
15.
Zhou, Dao, Jiahui Guo, Hesen Liu, et al.. (2016). Distributed Data Analytics Platform for Wide-Area Synchrophasor Measurement Systems. IEEE Transactions on Smart Grid. 7(5). 2397–2405. 49 indexed citations
16.
Gui, Xun, Rui Li, Xuhui Zhang, et al.. (2014). An important amino acid in nucleoprotein contributes to influenza A virus replication by interacting with polymerase PB2. Virology. 464-465. 11–20. 8 indexed citations
17.
Chen, Yixin, Xun Gui, Kunyu Yang, et al.. (2010). A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009. Journal of Virological Methods. 167(1). 100–102. 18 indexed citations
18.
Chen, Yingwei, Wenxin Luo, Zhong Fang, et al.. (2010). Humanized antibodies with broad-spectrum neutralization to avian influenza virus H5N1. Antiviral Research. 87(1). 81–84. 8 indexed citations
19.
Gui, Xun. (2003). Wall-Slip Phenomenon of Lubricating Grease Flowing in Steel Tube. Journal of China University of Mining and Technology.
20.
Huggins, John W., Thomas M. Cosgriff, Meng Guang, et al.. (1991). Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome. The Journal of Infectious Diseases. 164(6). 1119–1127. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026